Template:Antiphospholipid syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(5 intermediate revisions by 4 users not shown)
Line 11: Line 11:
!
!
[[Antiphospholipid syndrome|Home]]
[[Antiphospholipid syndrome|Home]]
|-
!
|- bgcolor="Pink"
!
[[Antiphospholipid syndrome (patient information)|Patient Information]]
|-  
|-  
!
!
Line 52: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphospholipid syndrome differential diagnosis|Differentiating Antiphospholipid syndrome from other Diseases]]
[[Differentiating Antiphospholipid syndrome from other diseases|Differentiating Antiphospholipid syndrome from other Diseases]]
|-  
|-  
!
!
Line 65: Line 59:
!
!
[[Antiphospholipid syndrome risk factors|Risk Factors]]
[[Antiphospholipid syndrome risk factors|Risk Factors]]
|-
!
|- bgcolor="Pink"
!
[[Antiphospholipid syndrome screening|Screening]]
|-  
|-  
!
!
Line 85: Line 73:
|-  
|-  
!
!
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphospholipid syndrome diagnostic criteria|Diagnostic Criteria]]
[[Antiphospholipid syndrome diagnostic criteria|Diagnostic criteria]]
|-  
|-  
!
!
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
Line 107: Line 93:
!
!
[[Antiphospholipid syndrome laboratory findings|Laboratory Findings]]
[[Antiphospholipid syndrome laboratory findings|Laboratory Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Antiphospholipid syndrome electrocardiogram|Electrocardiogram]]
|-  
|-  
!
!
Line 174: Line 154:
[[Antiphospholipid syndrome primary prevention|Primary Prevention]]
[[Antiphospholipid syndrome primary prevention|Primary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 180: Line 160:
[[Antiphospholipid syndrome secondary prevention|Secondary Prevention]]
[[Antiphospholipid syndrome secondary prevention|Secondary Prevention]]
|-  
|-  
!
|- bgcolor="PaleTurquoise"
!
[[Antiphospholipid syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
!
[[Antiphospholipid syndrome future or investigational therapies|Future or Investigational Therapies]]
|-
!


|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"

Latest revision as of 16:11, 24 April 2018